✦ LIBER ✦

Response of antibodies to oxidized LDL in hypercholesterolemic patients treated with HMG-CoA reductase inhibitors

✍ Scribed by M.N. Bui; G. Moutsatsos; M. Caulfield; C. Bui; B. Echard; C.E. Rackley

Book ID: 118589114
Publisher: Elsevier Science
Year: 1998
Tongue: English
Weight: 311 KB
Volume: 31
Category: Article
ISSN: 1558-3597
DOI: 10.1016/s0735-1097(98)80389-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Improved blood pressure control in hyper

Improved blood pressure control in hypertensive and hypercholesterolemic patients treated with HMG-CoA reductase inhibitors

✍ S. Bacchelli; C. Borghi; M.G. Prandin; V. Immordino; E. Ambrosioni 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 138 KB

PCVD10: ATTAINMENT OF LIPID GOALS IN PAT

PCVD10: ATTAINMENT OF LIPID GOALS IN PATIENTS TREATED WITH HMG-COA REDUCTASE INHIBITORS: A RETROSPECTIVE STUDY

✍ MB Nichol; J Jones; A David; DA Godolphin; E Bernstein 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

Effects of CS-514 (eptastatin), an inhib

Effects of CS-514 (eptastatin), an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, on serum lipid and apolipoprotein levels in heterozygous familial hypercholesterolemic patients treated by low density lipoprotein (LDL) -apheresis

✍ Hiroshi Mabuchi; Hajime Fujita; Ichiro Michishita; Mitsuaki Takeda; Kouji Kajina 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 456 KB

Evaluation of short-term safety and effi

Evaluation of short-term safety and efficacy of HMG-CoA reductase inhibitors in hypercholesterolemic patients with elevated serum alanine transaminase concentrations: PITCH study (PITavastatin versus atorvastatin to evaluate the effect on patients with hypercholesterolemia and mild to moderate hepatic damage)

✍ Ki Hoon Han; Seung Woon Rha; Hyun-Jae Kang; Jang-Whan Bae; Byoung-Joo Choi; So-Y 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 551 KB

Lipid-lowering response of the HMG-CoA r

Lipid-lowering response of the HMG-CoA reductase inhibitor fluvastatin is influenced by polymorphisms in the low-density lipoprotein receptor gene in Brazilian patients with primary hypercholesterolemia

✍ Luis A. Salazar; Mario H. Hirata; Éder C.R. Quintão; Rosario D.C. Hirata 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 63 KB 👁 2 views

Although the efficacy of fluvastatin (HMG-CoA reductase inhibitor) in the treatment of primary hypercholesterolemia is well documented, a wide interindividual variation treatment response has been observed. We have studied the possible role of the AvaII (exon 13), HincII (exon 12), and PvuII (intron